Relative roles of various efflux pathways in net cholesterol efflux from macrophage foam cells in atherosclerotic lesions
Y Zhao, TJC Van Berkel, M Van Eck - Current opinion in lipidology, 2010 - journals.lww.com
Y Zhao, TJC Van Berkel, M Van Eck
Current opinion in lipidology, 2010•journals.lww.comRecent advances in the understanding of the regulation of cholesterol transporters and their
acceptors in atherosclerotic lesions indicate that HDL-based therapies should aim to
enhance the activity of cholesterol transporters and improve both the quantity and quality of
HDL.
acceptors in atherosclerotic lesions indicate that HDL-based therapies should aim to
enhance the activity of cholesterol transporters and improve both the quantity and quality of
HDL.
Summary
Recent advances in the understanding of the regulation of cholesterol transporters and their acceptors in atherosclerotic lesions indicate that HDL-based therapies should aim to enhance the activity of cholesterol transporters and improve both the quantity and quality of HDL.
Lippincott Williams & Wilkins